Moderna
MRNA
#1188
Rank
โ‚ฌ14.51 B
Marketcap
37,72ย โ‚ฌ
Share price
-0.43%
Change (1 day)
-56.18%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) - Total assets

Total assets on the balance sheet as of September 2024 : โ‚ฌ15.13 Billion

According to Moderna 's latest financial reports the company's total assets are โ‚ฌ15.13 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Moderna - Total assets on balance sheet (from 2017 to 2024)

Total assets by year

Year Total assets Change
2023-12-31โ‚ฌ16.66 B-30.86%
2022-12-31โ‚ฌ24.10 B10.67%
2021-12-31โ‚ฌ21.78 B265.17%
2020-12-31โ‚ฌ5.96 B320.42%
2019-12-31โ‚ฌ1.41 B-17.28%
2018-12-31โ‚ฌ1.71 B89.76%
2017-12-31โ‚ฌ0.90 B-32.91%
2016-12-31โ‚ฌ1.34 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
โ‚ฌ89.78 M-99.41%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ112.54 B 643.73%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ7.11 M-99.95%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ4.02 B-73.39%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ99.13 B 555.09%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚ฌ1.09 B-92.79%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ170.72 B 1,028.18%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA